Stopped early
Cardiac Cath Lab Staff Radiation Exposure
NCT03959072 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 2 Feb 2023
- What is being tested
- Robotic CTO PCI; Conventional (Manual) CTO PCI
- For
- Coronary Artery Disease; Chronic Total Occlusion of Coronary Artery; Percutaneous Coronary Intervention
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 74 people. The full rules are on the registry page.
- Where
- United States (3 sites)
- When
- Starts or started 5 Sept 2019, ends 15 Sept 2021. Registered 22 May 2019.
- Results
- None posted yet.
In the researchers' words
The objective of this randomized safety and observational study is to demonstrate CorPath GRX chronic total occlusion PCI is safe, and that Cardiac Catheterization Laboratory staff have no additional exposure to radiation when compared to conventional manual chronic total occlusion PCI procedures without added procedure time.
Sites
- St. Luke's Hospital of Kansas CityKansas City, Missouri, United States
- WellSpan York HospitalYork, Pennsylvania, United States
- University of WashingtonSeattle, Washington, United States